Advertisement

A new NBIA patient from Turkey with homozygous C19ORF12 mutation

  • Çiğdem Seher Kasapkara
  • Leyla Tümer
  • Allison Gregory
  • Fatih Ezgü
  • Aslı İnci
  • Betül Emine Derinkuyu
  • Rachel Fox
  • Caleb Rogers
  • Susan Hayflick
Letter to the Editor

Introduction

Neurodegeneration with brain iron accumulation (NBIA) comprises a group of disorders with a progressive extrapyramidal syndrome and excessive iron deposition in the brain, particularly globus pallidus and substantia nigra. NBIA is considered to be a very rare disease group, with a prevalence of less than 1/1,000,000 in the general population [1, 2, 3]. Ten genes have been identified as associated with different NBIA subtypes. Only two of these genes (FTL and CP) encode proteins that play a direct role in iron metabolism, while the remaining eight (PANK2, PLA2G6, C19orf12, WDR45, FA2H, ATP13A2, DCAF17, and COASY) encode proteins involved in lipid metabolism, mitochondrial function, coenzyme A (CoA) metabolism, and autophagy [4]. The most common forms of NBIA are pantothenate kinase-associated neurodegeneration (PKAN), PLA2G6-associated neurodegeneration (PLAN), and beta propeller protein-associated neurodegeneration (BPAN). Mitochondrial membrane protein-associated...

Notes

Acknowledgements

Sequencing was provided by the University of Washington Center for Mendelian Genomics (UW-CMG) and was funded by the National Human Genome Research Institute and the National Heart, Lung and Blood Institute Grant 2UM1HG006493 to Drs. Debbie Nickerson, Michael Bamshad, and Suzanne Leal.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments.

Informed consent

Informed consent was obtained from our patient’s family included in the study.

References

  1. 1.
    Selikhova M, Fedotova E, Wiethoff S, Schottlaender LV, Klyushnikov S, Illarioshkin SN, Houlden H (2017) A 30-year history of MPAN case from Russia. Clin Neurol Neurosurg 159:111–113.  https://doi.org/10.1016/j.clineuro.2017.05.025 CrossRefPubMedGoogle Scholar
  2. 2.
    Deutschländer A, Konno T, Ross OA (2017) Mitochondrial membrane protein-associated neurodegeneration. Parkinsonism Relat Disord 39:1–3.  https://doi.org/10.1016/j.parkreldis.2017.03.014 CrossRefPubMedGoogle Scholar
  3. 3.
    Olgiati S, Doğu O, Tufekcioglu Z, Diler Y, Saka E, Gultekin M, Kaleagasi H, Kuipers D, Graafland J, Breedveld GJ, Quadri M, Sürmeli R, Sünter G, Doğan T, Yalçın AD, Bilgiç B, Elibol B, Emre M, Hanagasi HA, Bonifati V (2017) The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN. Parkinsonism Relat Disord 39:64–70.  https://doi.org/10.1016/j.parkreldis.2017.03.012 CrossRefPubMedGoogle Scholar
  4. 4.
    Skowronska M, Kmiec T, Jurkiewicz E, Malczyk K, Kurkowska-Jastrzębska I, Czlonkowska A (2017) Evolution and novel radiological changes of neurodegeneration associated with mutations in C19orf12. Parkinsonism Relat Disord 39:71–76.  https://doi.org/10.1016/j.parkreldis.2017.03.013 CrossRefPubMedGoogle Scholar
  5. 5.
    Al Macki N, Al Rashdi I (2017) A novel deletion mutation of exon 2 of the C19orf12 gene in an Omani family with mitochondrial membrane protein-associated neurodegeneration (MPAN). Oman Med J 32(1):66–68.  https://doi.org/10.5001/omj.2017.12 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Gore E, Appleby BS, Cohen ML, DeBrosse SD, Leverenz JB, Miller BL, Siedlak SL, Zhu X, Lerner AJ (2016) Clinical and imaging characteristics of late onset mitochondrial membrane protein-associated neurodegeneration (MPAN). Neurocase 22(5):476–483CrossRefGoogle Scholar
  7. 7.
    Langwinska-Wosko E, Skowronska M, Kmiec T, Czlonkowska A (2016) Retinal and optic nerve abnormalities in neurodegeneration associated with mutations in C19orf12 (MPAN). J Neurol Sci 370:237–240.  https://doi.org/10.1016/j.jns.2016.09.046 CrossRefPubMedGoogle Scholar
  8. 8.
    Salomão RP, Pedroso JL, Gama MT, Dutra LA, Maciel RH, Godeiro-Junior C, Chien HF, Teive HA, Cardoso F, Barsottini OG (2016) A diagnostic approach for neurodegeneration with brain iron accumulation: clinical features, genetics and brain imaging. Arq Neuropsiquiatr 74(7):587–596.  https://doi.org/10.1590/0004-282X20160080 (review) CrossRefPubMedGoogle Scholar
  9. 9.
    Hogarth P (2015) Neurodegeneration with brain iron accumulation: diagnosis and management. J Mov Disord 8(1):1–13.  https://doi.org/10.14802/jmd.14034 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Yoganathan S, Sudhakar SV, Thomas M, Dutta AK, Danda S (2016) “Eye of tiger sign” mimic in an adolescent boy with mitochondrial membrane protein associated neurodegeneration (MPAN). Brain Dev 38(5):516–519.  https://doi.org/10.1016/j.braindev.2015.10.017 CrossRefPubMedGoogle Scholar
  11. 11.
    Meyer E, Kurian MA, Hayflick SJ (2015) Neurodegeneration with brain iron accumulation: genetic diversity and pathophysiological mechanisms. Annu Rev Genom Hum Genet 16:257–279.  https://doi.org/10.1146/annurev-genom-090314-025011 CrossRefGoogle Scholar
  12. 12.
    Tschentscher A, Dekomien G, Ross S, Cremer K, Kukuk GM, Epplen JT, Hoffjan S (2015) Analysis of the C19orf12 and WDR45 genes in patients with neurodegeneration with brain iron accumulation. J Neurol Sci 349(1–2):105–9.  https://doi.org/10.1016/j.jns.2014.12.036 CrossRefPubMedGoogle Scholar
  13. 13.
    Amaral LL, Gaddikeri S, Chapman PR, Roy R, Gaddikeri RS, Marussi VH, Bag AK (2015) Neurodegeneration with brain iron accumulation: clinicoradiological approach to diagnosis. J Neuroimaging 25(4):539–551.  https://doi.org/10.1111/jon.12195 CrossRefPubMedGoogle Scholar
  14. 14.
    Hartig M, Prokisch H, Meitinger T, Klopstock T (2013) Mitochondrial membrane protein-associated neurodegeneration (MPAN). Int Rev Neurobiol 110:73–84.  https://doi.org/10.1016/B978-0-12-410502-7.00004-1 CrossRefPubMedGoogle Scholar

Copyright information

© Belgian Neurological Society 2018

Authors and Affiliations

  • Çiğdem Seher Kasapkara
    • 1
  • Leyla Tümer
    • 2
  • Allison Gregory
    • 3
  • Fatih Ezgü
    • 2
  • Aslı İnci
    • 2
  • Betül Emine Derinkuyu
    • 4
  • Rachel Fox
    • 3
  • Caleb Rogers
    • 3
  • Susan Hayflick
    • 3
  1. 1.Department of Pediatric Metabolism and NutritionDr. Sami Ulus Maternity and Children’s Research and Education HospitalAnkaraTurkey
  2. 2.Department of Pediatric Metabolism and NutritionGazi University HospitalAnkaraTurkey
  3. 3.Molecular and Medical Genetics, Pediatrics and NeurologyOregon Health and Science UniversityPortlandUSA
  4. 4.Department of Pediatric RadiologyDr. Sami Ulus Maternity and Children’s Research and Education HospitalAnkaraTurkey

Personalised recommendations